The first-generation drug-eluting stents and coronary endothelial dysfunction

Area of Science:

• Cardiovascular Medicine
• Interventional Cardiology
• Biomaterials Science

Background:

• First-generation drug-eluting stents (1st-gen DES) are widely used for coronary artery disease.
• Clinical data suggest 1st-gen DES may cause delayed vasomotor dysfunction in non-stented arterial segments up to 12 months post-implantation.
• This contrasts with bare-metal stent outcomes.

Purpose of the Study:

• To systematically review clinical, pathophysiological, and histopathological data on 1st-gen DES-associated vascular endothelial dysfunction.
• To explore the underlying mechanisms, including delayed healing and impaired re-endothelialization.
• To discuss newer DES generations and endothelial-friendly technologies.

Main Methods:

• Systematic literature review of clinical studies.
• Analysis of pathophysiological mechanisms.
• Review of histopathological findings.
• Evaluation of data on newer DES and emerging technologies.

Main Results:

• 1st-gen DES implantation is associated with coronary artery vasomotor dysfunction at non-stented segments.
• Delayed arterial healing and poor re-endothelialization are implicated mechanisms.
• Understanding long-term safety is crucial due to widespread DES use.

Conclusions:

• Further research into 1st-gen DES safety and mechanisms of vascular dysfunction is warranted.
• Newer DES generations and endothelial-friendly technologies may offer improved safety profiles.
• Comprehensive understanding of DES impact on vascular health is essential for patient outcomes.